CD63 and cancer: We propose that uncoupling the TIMP-1–CD63 signaling cascade would reverse the glucose metabolic switch and the CAIX-mediated acidosis in malignant tumor tissues in addition to inhibition of intrinsic and extrinsic apoptosis pathways.